Home » Commentaries


Challenging Monolithic Conceptions of Complex Disorders: Schizophrenia and Autism Spectrum Disorder

By Chelsea A. Jack and Mark B. Herzog Two studies published this month—one about schizophrenia and the other about autism spectrum disorder—describe genetic and clinical ... Read more »

FDA Proposal for Regulating Laboratory Diagnostics Could Improve Patient Care

By Rachel Sachs Wendy Chung’s commentary last month about the FDA’s proposed draft guidance for the regulation of laboratory-developed tests (LDTs) is heavily critical of ... Read more »

The FDA Proposes Roadblocks to Laboratory Diagnostics

by Wendy Chung, MD, PhD Associate Professor of Pediatrics (in Medicine) Columbia University Medical Center The American laboratory industry and its ability to serve patients is being ... Read more »

A Decade’s Worth of Gene-Environment Interaction Studies, in Hindsight

By: Erik Parens In the early 2000s, Avshalom Caspi, Terrie Moffitt, and their colleagues published two papers, which suggested that we ... Read more »

Genetic Testing in Torts Litigation – Justice or Injustice?

By Maya Sabatello Genetic testing to identify the susceptibility of individuals to developing specific disorders or to confirm diagnoses is becoming increasingly common in clinical ... Read more »

Alzheimer’s Disease, Biomarkers, and Suicide: Why We Need to Think About All Three Together

By Nancy Berlinger, PhD Recently, I spoke with a seasoned health care reporter who was interested in Alzheimer’s and biomarkers because of his own family’s ... Read more »

Genetic Information Not Always Benign

Knowledge About Dementia Predisposition Reduces Cognitive Performance December 23, 2013 By: Paul S. Appelbaum, M.D. Ethicists and others have been concerned that the disclosure of ... Read more »

Prenatal Identification of Increased Risk for Schizophrenia

January 9, 2014 By: Josephine Johnston The introduction in 2011 of new, highly accurate, non-invasive prenatal genetic tests garnered a significant amount of media attention. ... Read more »

The FDA and 23andMe: Overreaching and overreacting?

December 20, 2013 By: Josephine Johnston On November 22nd, the FDA sent a Warning Letter to 23andMe ordering it to immediately discontinue marketing and ... Read more »